Rustum Saad, Lübeck Sebastian, Beckmann Erik, Wilhelmi Mathias, Haverich Axel, Shrestha Malakh Lal
Department of Cardiothoracic, Transplantation, and Vascular Surgery, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
Center for Competence for Cardiovascular Implants, Hannover Medical School, Hannover, Germany.
Indian J Thorac Cardiovasc Surg. 2023 Mar;39(2):137-144. doi: 10.1007/s12055-022-01443-x. Epub 2023 Jan 3.
This study presents a single center's experience and analyzes clinical outcomes following elective open surgical descending aortic replacement.
Between January 2000 and August 2019, 96 patients with mean age 64 years (range, 49.5-71 years) (62.5% (=60) male) underwent elective descending aortic replacement due to aneurysm (=60) or chronic dissection (=36). Marfan syndrome was present in 12 patients (12.5%).
In-hospital mortality rate was 3.1% (= 3. 2 in the aneurysm group, 1 in the dissection group). New-onset renal insufficiency postoperatively with (creatinine ≥ 2.5 mg/dl) manifested in 10 patients (10.8%). One patient (1%) suffered from stroke, and paraplegia developed in 1 pts (1%). The median follow-up time was 7 years (IQR: 2.5-13 years). The 5- and 10-year survival rates were 70.8% and 50.7% respectively. We did not observe any early or late prosthetic graft infection. The Cox proportional hazards regression analysis identified age (HR: 1.044, 95% CI: 1.009-1.080, -value: 0.014), diabetes (HR: 2.544, 95% CI: 1.009-6.413, -value: 0.048), and chronic obstructive pulmonary disease (COPD) (HR: 2.259, 95% CI: 1.044-4.890, -value: 0.039) as risk factors for late mortality.
This study showed that the elective open surgical replacement of the descending aorta can be achieved with excellent outcomes in terms of perioperative mortality and morbidity. Prosthetic graft is not a problem with open surgical descending aortic replacement, even in the long term.
The online version contains supplementary material available at 10.1007/s12055-022-01443-x.
本研究展示了一个单中心的经验,并分析了择期开放性降主动脉置换术后的临床结果。
在2000年1月至2019年8月期间,96例平均年龄64岁(范围49.5 - 71岁)(62.5%(=60)为男性)因动脉瘤(=60)或慢性夹层(=36)接受了择期降主动脉置换术。12例患者(12.5%)患有马凡综合征。
住院死亡率为3.1%(动脉瘤组为3.2%,夹层组为1%)。术后新发肾功能不全(肌酐≥2.5mg/dl)的患者有10例(10.8%)。1例患者(1%)发生中风,1例患者(1%)出现截瘫。中位随访时间为7年(四分位间距:2.5 - 13年)。5年和10年生存率分别为70.8%和50.7%。我们未观察到任何早期或晚期人工血管感染。Cox比例风险回归分析确定年龄(风险比:1.044,95%置信区间:1.009 - 1.080,P值:0.014)、糖尿病(风险比:2.544,95%置信区间:1.009 - 6.413,P值:0.048)和慢性阻塞性肺疾病(COPD)(风险比:2.259,95%置信区间:1.044 - 4.890,P值:0.039)为晚期死亡的风险因素。
本研究表明,择期开放性降主动脉置换术在围手术期死亡率和发病率方面可取得优异的结果。即使从长期来看,人工血管也不是开放性降主动脉置换术的问题。
在线版本包含可在10.1007/s12055 - 022 - 01443 - x获取的补充材料。